Cryofocus Medtech (Shanghai) Co., Ltd. (HKG:6922)

Market Cap	1.57B
Revenue (ttm)	93.32M
Net Income (ttm)	-83.29M
Shares Out	239.11M
EPS (ttm)	-0.35
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,400
Average Volume	120,110
Open	6.54
Previous Close	6.55
Day's Range	6.53 - 6.54
52-Week Range	3.20 - 14.02
Beta	-1.08
RSI	52.32
Earnings Date	Mar 27, 2026

About HKG:6922

Cryofocus Medtech (Shanghai) Co., Ltd., a medical device company, engages in the research and development, manufacture, and sale of cryoablation minimally invasive interventional treatment technology and related medical products in the People’s Republic of China. The company develops products in the areas of vascular interventional therapy for the treatment of atrial fibrillation, hypertension, and other cardiovascular diseases; and natural orifice transluminal endoscopic surgery for the treatment of urinary, respiratory, and digestive diseases...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2013
• Employees: 276
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 6922

Financial Performance

In 2024, HKG:6922's revenue was 53.53 million, an increase of 30.72% compared to the previous year's 40.95 million. Losses were -104.37 million, 7.06% more than in 2023.

Financial numbers in CNY